Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J.

Nat Med. 2011 Jul 31;17(8):952-60. doi: 10.1038/nm.2411.

2.

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd.

Sci Transl Med. 2011 Jun 1;3(85):85ra46. doi: 10.1126/scitranslmed.3002231.

3.

Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab.

Sethna C, Benchimol C, Hotchkiss H, Frank R, Infante L, Vento S, Trachtman H.

J Transplant. 2011;2011:389542. doi: 10.1155/2011/389542. Epub 2011 Apr 26.

4.

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L, Benetti E, Scozzola F, Pasini A, Dallera N, Sica F, Belingheri M, Scolari F, Ghiggeri GM.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1308-15. doi: 10.2215/CJN.09421010. Epub 2011 May 12.

5.

Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review.

Vinai M, Waber P, Seikaly MG.

Pediatr Transplant. 2010 May;14(3):314-25. doi: 10.1111/j.1399-3046.2009.01261.x. Review.

PMID:
20519016
6.

Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report.

Grenda R, Jarmużek W, Piątosa B, Rubik J.

Pediatr Transplant. 2011 Sep;15(6):E121-5. doi: 10.1111/j.1399-3046.2010.01303.x. Epub 2010 Mar 16.

PMID:
20331516
7.

Rituximab in refractory nephrotic syndrome.

Prytuła A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A, Taylor M, Marks SD, Tuchman S, Camilla R, Ognjanovic M, Filler G, Smith G, Tullus K.

Pediatr Nephrol. 2010 Mar;25(3):461-8. doi: 10.1007/s00467-009-1376-6. Epub 2009 Dec 23.

PMID:
20033225
8.

Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation.

Ponticelli C.

Nephrol Dial Transplant. 2010 Jan;25(1):25-31. doi: 10.1093/ndt/gfp538. Epub 2009 Oct 28. Review. No abstract available.

PMID:
19875378
9.

Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.

Rodríguez-Ferrero M, Ampuero J, Anaya F.

Transplant Proc. 2009 Jul-Aug;41(6):2406-8. doi: 10.1016/j.transproceed.2009.06.044.

PMID:
19715934
10.

Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.

Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.

Transplantation. 2009 Aug 15;88(3):417-20. doi: 10.1097/TP.0b013e3181aed9d7.

PMID:
19667947
11.

Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.

Freiberger V, Amann K, Heemann U, Frank H.

Transpl Int. 2009 Nov;22(11):1110-3. doi: 10.1111/j.1432-2277.2009.00897.x. Epub 2009 May 20.

12.

Nephrotic syndrome and rituximab: facts and perspectives.

Haffner D, Fischer DC.

Pediatr Nephrol. 2009 Aug;24(8):1433-8. doi: 10.1007/s00467-009-1226-6. Epub 2009 Jun 4. Review.

PMID:
19495800
13.

Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.

Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD.

Transplantation. 2009 Apr 27;87(8):1232-9. doi: 10.1097/TP.0b013e31819f12be.

PMID:
19384172
14.

Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome.

Iharada A, Kaneko K, Tsuji S, Hasui M, Kanda S, Nishiyama T.

Pediatr Nephrol. 2009 May;24(5):1033-8. doi: 10.1007/s00467-008-1092-7. Epub 2009 Jan 20.

PMID:
19153775
15.

Rituximab for post-transplant recurrences of FSGS.

Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M.

Pediatr Transplant. 2009 Mar;13(2):240-3. doi: 10.1111/j.1399-3046.2008.00967.x. Epub 2008 Sep 4.

PMID:
18822107
16.

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.

Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F.

Pediatr Nephrol. 2008 Aug;23(8):1269-79. doi: 10.1007/s00467-008-0814-1. Epub 2008 May 9.

PMID:
18465150
17.

Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation.

Apeland T, Hartmann A.

Nephrol Dial Transplant. 2008 Jun;23(6):2091-4. doi: 10.1093/ndt/gfn099. Epub 2008 Mar 4. No abstract available.

PMID:
18319357
18.

Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy.

El-Firjani A, Hoar S, Karpinski J, Bell R, Deschenes MJ, Knoll GA.

Nephrol Dial Transplant. 2008 Jan;23(1):425. Epub 2007 Nov 2. No abstract available.

PMID:
17981882
19.

Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.

Yabu JM, Ho B, Scandling JD, Vincenti F.

Am J Transplant. 2008 Jan;8(1):222-7. Epub 2007 Nov 2.

20.

Supplemental Content

Support Center